Oncotarget

Vol 9, No 45

June 12, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 45 of Oncotarget features Figure 7D, "HMEC cells were transduced with LV-FOXP3 KD or LV-control at an MOI = 1," by Brown, et al.

Table of Contents

Research Papers: Immunology

Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer

Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer

https://doi.org/10.18632/oncotarget.25496

Andrea Zapater-Moros, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, Lucía Trilla-Fuertes, Jorge M. Arevalillo, Mariana Díaz-Almirón, Hilario Navarro, Paloma Maín, Jaime Feliú, Pilar Zamora, Enrique Espinosa,  and Juan Ángel Fresno Vara
27586-27594
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Research Papers

Malignant transformation of uterine leiomyoma to myxoid leiomyosarcoma after morcellation associated with ALK rearrangement and loss of 14q

Malignant transformation of uterine leiomyoma to myxoid leiomyosarcoma after morcellation associated with ALK rearrangement and loss of 14q

https://doi.org/10.18632/oncotarget.25137

Carsten Holzmann, Christian Saager, Gunhild Mechtersheimer, Dirk Koczan, Burkhard M. Helmke,  and Jörn Bullerdiek
27595-27604
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Comprehensive identification of long noncoding RNAs in colorectal cancer

Comprehensive identification of long noncoding RNAs in colorectal cancer

https://doi.org/10.18632/oncotarget.25218

Eric James de Bony, Martin Bizet, Olivier Van Grembergen, Bouchra Hassabi, Emilie Calonne, Pascale Putmans, Gianluca Bontempi,  and François Fuks
27605-27629
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Inhibition of GSK3α/β impairs the progression of HNSCC

Inhibition of GSK3α/β impairs the progression of HNSCC

https://doi.org/10.18632/oncotarget.25250

Lisa Schulz, Ralph Pries, Aruna Sree Lanka, Maren Drenckhan,  and Barbara Wollenberg
27630-27644
Abstract  |  PDF  |  HTML  |  Order a Reprint

The small molecule STF-62247 induces apoptotic and autophagic cell death in leukemic cells

The small molecule STF-62247 induces apoptotic and autophagic cell death in leukemic cells

https://doi.org/10.18632/oncotarget.25291

Tomohiro Kozako, Keisuke Sato, Yuichiro Uchida, Naho Kato, Akiyoshi Aikawa, Kentaro Ogata, Hidetoshi Kamimura, Haruna Uemura, Makoto Yoshimitsu, Kenji Ishitsuka, Yasuki Higaki, Hiroaki Tanaka, Shin-Ichiro Honda,  and Shinji Soeda
27645-27655
Abstract  |  PDF  |  HTML  |  Order a Reprint

Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer

Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer

https://doi.org/10.18632/oncotarget.24441

Jong-Young Lee, Seok Joong Yun, Pildu Jeong, Xuan-Mei Piao, Ye-Hwan Kim, Jihye Kim, Sathiyamoorthy Subramaniyam, Young Joon Byun, Ho Won Kang, Sung Phil Seo, Jayoung Kim, Jung Min Kim, Eun Sang Yoo, Isaac Y. Kim, Sung-Kwon Moon, Yung Hyun Choi,  and Wun-Jae Kim
27656-27666
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells

Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells

https://doi.org/10.18632/oncotarget.25351

Jacinth Rajendra, Keshava K. Datta, Sheikh Burhan Ud Din Farooqee, Rahul Thorat, Kiran Kumar, Nilesh Gardi, Ekjot Kaur, Jyothi Nair, Sameer Salunkhe, Ketaki Patkar, Sanket Desai, Jayant Sastri Goda, Aliasgar Moiyadi, Amit Dutt, Prasanna Vankatraman, Harsha Gowda,  and Shilpee Dutt
27667-27681
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model

New susceptibility loci for cutaneous melanoma risk and progression revealed using a porcine model

https://doi.org/10.18632/oncotarget.25455

Emmanuelle Bourneuf, Jordi Estellé, Amandine Blin, Françoise Créchet, Maria del Pilar Schneider, Hélène Gilbert, Myriam Brossard, Amaury Vaysse, Mark Lathrop, Silvia Vincent-Naulleau,  and Florence Demenais
27682-27697
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer

PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer

https://doi.org/10.18632/oncotarget.25498

Yota Yasumizu, Hiroshi Hongo, Takeo Kosaka, Shuji Mikami, Koshiro Nishimoto, Eiji Kikuchi,  and Mototsugu Oya
27698-27707
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

FOXP3 and miR-155 cooperate to control the invasive potential of human breast cancer cells by down regulating ZEB2 independently of ZEB1

FOXP3 and miR-155 cooperate to control the invasive potential of human breast cancer cells by down regulating ZEB2 independently of ZEB1

https://doi.org/10.18632/oncotarget.25523

Cheryl Y. Brown, Sonia Dayan, Soon Wei Wong, Adrian Kaczmarek, Christopher M. Hope, Stephen M. Pederson, Victoria Arnet, Gregory J. Goodall, Darryl Russell, Timothy J. Sadlon,  and Simon C. Barry
27708-27727
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma

Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma

https://doi.org/10.18632/oncotarget.25543

Masaki Yoshioka, Tomoo Matsutani, Ayaka Hara, Seiichiro Hirono, Takaki Hiwasa, Masaki Takiguchi,  and Yasuo Iwadate
27728-27735
Abstract  |  PDF  |  HTML  |  Order a Reprint

ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer

ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer

https://doi.org/10.18632/oncotarget.25552

Karineh Petrossian, Noriko Kanaya, Chiao Lo, Pei-Yin Hsu, Duc Nguyen, Lixin Yang, Lu Yang, Charles Warden, Xiwei Wu, Raju Pillai, Lauren Bernal, Chiun-Sheng Huang, Laura Kruper, Yuan Yuan, George Somlo, Joanne Mortimer,  and Shiuan Chen
27736-27751
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The difference in the survival rate of patients with metastatic renal cell carcinoma in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center criteria

The difference in the survival rate of patients with metastatic renal cell carcinoma in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center criteria

https://doi.org/10.18632/oncotarget.25554

Satoshi Tamada, Taro Iguchi, Sayaka Yasuda, Minoru Kato, Takeshi Yamasaki,  and Tatsuya Nakatani
27752-27759
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma

Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma

https://doi.org/10.18632/oncotarget.25570

Güliz Acker, Sophie Käthe Piper, Anna Lena Datwyler, Thomas Broggini, Irina Kremenetskaia, Melina Nieminen-Kelhä, Janet Lips, Ulrike Harms, Susanne Mueller, Gilla Lättig-Tünnemann, Eveline Trachsel, Alessandro Palumbo, Dario Neri, Jan Klohs, Matthias Endres, Peter Vajkoczy, Christoph Harms,  and Marcus Czabanka
27760-27772
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Activating HER3 mutations in breast cancer

Activating HER3 mutations in breast cancer

https://doi.org/10.18632/oncotarget.25576

Rosalin Mishra, Samar Alanazi, Long Yuan, Thomas Solomon, Tarjani M. Thaker, Natalia Jura,  and Joan T. Garrett
27773-27788
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer

https://doi.org/10.18632/oncotarget.25578

Akito Hata, Daijiro Harada, Chiyuki Okuda, Reiko Kaji, Yoshio Masuda, Yoshika Takechi, Toshiyuki Kozuki, Naoyuki Nogami,  and Nobuyuki Katakami
27789-27796
Abstract  |  PDF  |  HTML  |  Order a Reprint

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches

https://doi.org/10.18632/oncotarget.25591

Maarten Versteven, Johan M.J. Van den Bergh, Katrijn Broos, Fumihiro Fujiki, Diana Campillo-Davo, Hans De Reu, Soyoko Morimoto, Quentin Lecocq, Marleen Keyaerts, Zwi Berneman, Haruo Sugiyama, Viggo F.I. Van Tendeloo, Karine Breckpot,  and Eva Lion
27797-27808
Abstract  |  PDF  |  HTML  |  Order a Reprint

The rabbit as an orthologous small animal model for APOBEC3A oncogenesis

The rabbit as an orthologous small animal model for APOBEC3A oncogenesis

https://doi.org/10.18632/oncotarget.25593

Hélène C. Laude, Vincent Caval, Mohamed S. Bouzidi, Xiongxiong Li, Florence Jamet, Michel Henry, Rodolphe Suspène, Simon Wain-Hobson,  and Jean-Pierre Vartanian
27809-27822
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs

A novel oncogenic role for urokinase receptor in leukemia cells: molecular sponge for oncosuppressor microRNAs

https://doi.org/10.18632/oncotarget.25597

Anna Li Santi, Anna Gorrasi, Mariaevelina Alfieri, Nunzia Montuori,  and Pia Ragno
27823-27834
Abstract  |  PDF  |  HTML  |  Order a Reprint

Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells

Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells

https://doi.org/10.18632/oncotarget.25600

Anke Rauch, Annemarie Carlstedt, Claudia Emmerich, Al-Hassan M. Mustafa, Anja Göder, Shirley K. Knauer, Michael Linnebacher, Thorsten Heinzel,  and Oliver H. Krämer
27835-27850
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Clinical Research Papers

Feasibility of using stereotactic body radiation therapy for unresectable soft tissue tumors of the trunk

Feasibility of using stereotactic body radiation therapy for unresectable soft tissue tumors of the trunk

https://doi.org/10.18632/oncotarget.25539

Eun Kyung Paik, Mi-Sook Kim, Chul-Koo Cho, Hyung Jun Yoo, Won Il Jang, Young-Seok Seo, Sung-Ho Jin, Dae Geun Jeon,  and Dong Han Lee
27851-27857
Abstract  |  PDF  |  HTML  |  Order a Reprint

Interferon-stimulated gene 20 kDa protein serum levels and clinical outcome of hepatitis B virus-related liver diseases

Interferon-stimulated gene 20 kDa protein serum levels and clinical outcome of hepatitis B virus-related liver diseases

https://doi.org/10.18632/oncotarget.25559

Hoang Van Tong, Nghiem Xuan Hoan, Mai Thanh Binh, Dao Thanh Quyen, Christian G. Meyer, Le Huu Song, Nguyen Linh Toan,  and Thirumalaisamy P. Velavan
27858-27871
Abstract  |  PDF  |  HTML  |  Order a Reprint

Dietary patterns and primary liver cancer in Chinese adults: a case-control study

Dietary patterns and primary liver cancer in Chinese adults: a case-control study

https://doi.org/10.18632/oncotarget.23910

Qiu-Ye Lan, Gong-Cheng Liao, Rui-Fen Zhou, Pei-Yan Chen, Xiao-Yan Wang, Min-Shan Chen, Yu-Ming Chen,  and Hui-Lian Zhu
27872-27881
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Clinical Reviews

Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature

Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature

https://doi.org/10.18632/oncotarget.25328

Andrea Kuendgen, Catharina Müller-Thomas, Michael Lauseker, Torsten Haferlach, Petra Urbaniak, Thomas Schroeder, Carolin Brings, Michael Wulfert, Manja Meggendorfer, Barbara Hildebrandt, Beate Betz, Brigitte Royer-Pokora, Norbert Gattermann, Rainer Haas, Ulrich Germing,  and Katharina S. Götze
27882-27894
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Reviews

Breast cancer recurrence after reconstruction: know thine enemy

Breast cancer recurrence after reconstruction: know thine enemy

https://doi.org/10.18632/oncotarget.25602

Elizabeth A. Brett, Matthias M. Aitzetmüller, Matthias A. Sauter, Georg M. Huemer, Hans-Günther Machens,  and Dominik Duscher
27895-27906
Abstract  |  PDF  |  HTML  |  Order a Reprint

Corrections

Correction: Dietary cholesterol intake and stroke risk: a meta-analysis

Correction: Dietary cholesterol intake and stroke risk: a meta-analysis

https://doi.org/10.18632/oncotarget.25644

Pengfei Cheng, Junxi Pan, Jinjun Xia, Wen Huang, Shunjie Bai, Xiaofeng Zhu, Weihua Shao, Haiyang Wang,  and Peng Xie
27907-27907
Correction  |  PDF

Correction: Endonuclease G promotes mitochondrial genome cleavage and replication

Correction: Endonuclease G promotes mitochondrial genome cleavage and replication

https://doi.org/10.18632/oncotarget.25645

Rahel Stefanie Wiehe, Boris Gole, Laurent Chatre, Paul Walther, Enrico Calzia, Anja Palmer, J. Christof M. Gebhardt, Miria Ricchetti,  and Lisa Wiesmüller
27908-27908
Correction  |  PDF


Copyright © 2018 Impact Journals
Impact Journals is a registered trademark of Impact Journals, LLC